Department of Spine Section, Baoji Hospital of TCM, Baoji, China.
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):9000-9008. doi: 10.26355/eurrev_201910_19300.
The aim of this study was to elucidate whether the knockdown of microRNA-106-3p (miR-106-3p) could mediate the nerve regeneration and functional recovery after the spinal cord injury (SCI) and its potential mechanism.
Microglia were extracted from the cerebral cortex of the neonatal rats and cultured in vitro. Subsequently, biomarkers of M1-type and M2-type in microglia transfected with miR-106-3p inhibitor were measured. Furthermore, in vivo SCI model in rats was successfully constructed, and SCI rats were intrathecally injected with miR-106-3p inhibitor or negative control. The expressions of the pro-inflammatory factors in the SCI rats or controls were detected by the enzyme-linked immunosorbent assay (ELISA). The glial scar marker and extracellular matrix were visualized by Western blotting and immunofluorescence, respectively. To observe the nerve function in rats, the movement evaluation was conducted using Basso-Beattie-Bresnahan (BBB) locomotor rating scale.
In the inflammatory microglia, miR-106-3p was markedly up-regulated. Western blotting exhibited the downregulation of M1-type cells and the upregulation of M2-type cells after silencing miR-106-3p. In SCI rats, we discovered that the miR-106-3p level in the injured spinal cord was up-regulated within one week following injury. Meanwhile, the levels of the pro-inflammatory factors were significantly reduced in SCI rats with the miR-106-3p knockdown. At 7 days after the injury, the area of the astrocyte scar in the injured spinal cord was remarkably reduced by in vivo knockdown of miR-106-3p. Moreover, the extracellular matrix components secreted in the scar were also significantly inhibited. However, the glial secretion of the neurotrophic factors relatively increased in the SCI rats with the miR-106-3p knockdown. Neurological function recovery was pronounced in SCI rats with the miR-106-3p knockdown relative to controls.
The silence of miR-106-3p promotes the recovery of the locomotor function and protects the environment of the neurotization by inactivating inflammatory microglia and reducing the scar formation following SCI.
本研究旨在阐明微小 RNA-106-3p(miR-106-3p)的敲低是否可以介导脊髓损伤(SCI)后的神经再生和功能恢复及其潜在机制。
从小鼠大脑皮质中提取小胶质细胞并进行体外培养。随后,检测转染 miR-106-3p 抑制剂的小胶质细胞中 M1 型和 M2 型的生物标志物。此外,成功构建了大鼠体内 SCI 模型,并向 SCI 大鼠鞘内注射 miR-106-3p 抑制剂或阴性对照。通过酶联免疫吸附测定(ELISA)检测 SCI 大鼠或对照大鼠中促炎因子的表达。通过 Western 印迹和免疫荧光分别可视化神经胶质瘢痕标志物和细胞外基质。为了观察大鼠的神经功能,使用 Basso-Beattie-Bresnahan(BBB)运动评分量表进行运动评估。
在炎症性小胶质细胞中,miR-106-3p 明显上调。Western 印迹显示沉默 miR-106-3p 后 M1 型细胞下调,M2 型细胞上调。在 SCI 大鼠中,我们发现损伤后一周内损伤脊髓中 miR-106-3p 水平升高。同时,miR-106-3p 敲低的 SCI 大鼠中促炎因子水平显著降低。损伤后 7 天,体内敲低 miR-106-3p 可显著减少损伤脊髓中星形胶质细胞瘢痕的面积。此外,瘢痕中分泌的细胞外基质成分也明显受到抑制。然而,miR-106-3p 敲低的 SCI 大鼠中神经营养因子的胶质分泌相对增加。与对照组相比,miR-106-3p 敲低的 SCI 大鼠运动功能恢复更为明显。
沉默 miR-106-3p 通过使炎症性小胶质细胞失活并减少 SCI 后瘢痕形成,促进运动功能的恢复并保护神经化环境。